Price
No data yet.
Social Signal Score
Analyst Ratings
13 analystsRevenue
$70.51M+595.69%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- David R. Bailey
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 602
- Beta
- 0.98
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 2.02
Financials
Revenue
$70.51M+595.7%Net Income
$-7.16MEBITDA
$-4.40M-8403.8%Free Cash Flow
$-3.12MEPS (diluted)
$-0.30Shares Outstanding (diluted)
23.87M+217.7%Operating Expenses
$56.43MCash & Debt
$45.88MReturn of Capital
$0.00Revenue by Segment (annual)
$236.35MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $236.35M | $-39.65M | $-1.69 |
| 2024 | $204.73M | $-37.82M | $-1.64 |
| 2023 | $148.73M | $-20.97M | $-0.92 |
| 2022 | $122.29M | $1.26M | $0.06 |
| 2021 | $98.05M | $-16.26M | $-0.84 |
| 2020 | $71.08M | $-32.94M | $-1.82 |
| 2019 | $72.55M | $-13.73M | $-1.18 |
| 2018 | $57.56M | $-12.03M | $-0.96 |
| 2017 | $45.62M | $-8.93M | $-1.85 |
| 2016 | $37.30M | $-6.57M | $-0.87 |
| 2015 | $31.00M | $-7.89M | $-1.05 |
| 2014 | $23.68M | $-9.55M | $-1.28 |
Valuation
KIDShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (4)
- Newsglobenewswire.com·5d ago·Neutral
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries
View source ↗ - Newsglobenewswire.com·14d ago·Neutral
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
View source ↗ - Newsglobenewswire.com·42d ago·Neutral
OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology
View source ↗ - Newsmarketbeat.com·52d ago·Neutral
OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter OrthoPediatrics NASDAQ: KIDS reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord Genuity Growth Conference.
View source ↗
Earnings
Tue, Oct 27(in 3 weeks)
Consensus estimate $-0.23 per share
Typical surprise +7.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$-0.26 vs $-0.30beat
- Thu, Apr 30$-0.42 vs $-0.38miss
- Thu, Feb 26$-0.43 vs $-0.37miss
- Tue, Oct 28$-0.24 vs $-0.26beat
- Tue, Aug 5$-0.11 vs $-0.17beat
- Wed, May 7$-0.39 vs $-0.26miss
Estimates and results for KIDS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by KIDS officers and directors.
- Bought
- $99k
- Sold
- $49.3m
1 trade
39 trades
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
- Pelizzon David Rsold
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
- Pelizzon David Rsold
- Squadron Capital Llcsold
- Pritzker Jennifer N.sold
60 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Greg Gianfortehouse · MT00 · disclosed Jun 25, 2020 (7d later)Buy$15,001 - $50,000
- Greg Gianfortehouse · MT00 · disclosed Feb 14, 2020 (30d later)Buy$50,001 - $100,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.